SearchMenu

Investors

Upcoming results

We will announce our third quarter 2025 results on Wednesday 29 October.

Q3 2025 resultsAnnual Report 2024
Emma Walmsley headshot
Close video

We’re confident in our future

With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide.

Why invest in GSK?

Speeches and presentations

Julie Brown sat on a grey sofa smiling

BofA 2025 Global Healthcare Conference, London

24 September 2025

Julie Brown, Chief Financial Officer and Tony Wood, Chief Scientific Officer, participated in a fireside chat at the BofA Global Healthcare Conference in London on Wednesday, 24 September 2025.

Hesham Abdullah standing in front of the office

Morgan Stanley 23rd Annual Global Healthcare Conference

09 September 2025

Hesham Abdullah, SVP, Global Oncology R&D, participated at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York on Tuesday, 9 September 2025.

Tony Wood

Citi European Healthcare Conference, London

17 June 2025

Tony Wood, Chief Scientific Officer, attended the Citi European Healthcare Conference in London on Tuesday, 17 June 2025.

Dr Kimberly Smith

Goldman Sachs Global Healthcare Conference

09 June 2025

Kimberly Smith, Head of R&D at ViiV Healthcare, attended the Goldman Sachs Global Healthcare Conference in Miami on Monday, 9 June 2025.

David Redfern

NYSE Health Care Virtual Investor Access Day

05 June 2025

David Redfern, President Corporate Development, attended the NYSE Health Care Virtual Investor Access Day on Thursday, 5 June 2025.

Shareholder information

Shareholder information

GSK dividend

GSK laboratory photo

Dividend calculators (GBp/USD)

Calculate an estimate of your dividend payment

GSK lab equipment photo

Dividend calendar

Details of our dividend timetable by quarter

GSK share price

Share price tool

Detailed information on GSK's share price, including an interactive chart

Go to share price tool

Behind the science

Read our latest articles

'We’re innovating to help keep COPD patients out of hospital and exacerbation-free'

'Prevention is the best medicine to stop disease before it starts'

‘I was the sickest anyone could ever be’: Why young people are at risk of meningitis and what needs to change to reduce it

‘Digital biological twins and organoids might sound like sci-fi, but they’re real – and we’re using them to fight cancer’

‘I feel hopeless and frustrated’: Why patients living with incurable blood cancers need more treatment options

‘Finding the right treatment for my asthma and nasal polyps has transformed my life. I hope my experience can help others achieve the same’

‘How do we improve trust in prevention? The answer lies closer to home than you might think’

‘We’re aiming to protect even more children’: Research starts on second-generation malaria vaccine to prevent most severe form of disease

‘Cancer doesn’t have to be a deadly disease – it’s our goal to make it curable’

Vaccinations are not just for children: why adult immunisation is a health and economic necessity

Behind the science magazine
two scientists talking

Get in touch with our investor team

Investor contact details

You might also like

GSK quality lab operator carrying out activity

Pipeline

Our pipeline is focused on unlocking the science of the immune system and advanced technologies to develop innovative medicines and vaccines

Ware 3 2022 Prodqc 38 Hess

Our leading scientists

Meet the world-leading scientists who are uniting science, technology and talent to get ahead of disease together.

GSK Chair, Jon Symonds speaks, at podium on stage, at 2024 AGM

Governance

At GSK we are committed to operating at the highest standards of corporate governance

Continue to Media